Stay Informed: Transforming Radiology with Structured Reporting and Data-Driven Approaches

Dive into our activities, projects, and product updates. Catch on the latest industry news and learn who we are as a company and as a team.

Central Imaging Review Analysis with mint Lesion

Central Imaging Review Analysis with mint Lesion - read-ready in minutes, not weeks

Watch in the video above a demonstration of our central imaging review software featuring a pre-configured, master trial workflow database designed to support your study requirements with read-ready functionality quickly available.

  • Multiple read paradigms: Support for single reads, double reads with adjudication, and eligibility workflows
  • Multi-criteria reads: Apply multiple evaluation frameworks to the same image
  • Flexible templates: Use standard response criteria read templates or custom eCRFs you design
  • Built-in analytics: Volumetrics, SUVs, tumor growth rates, and radiomics capabilities
  • Automated notifications: Alerts configured to align with your review flow
  • Export functionality: One-click exports for images, data (CDISC, radiomics, observations), and structured results

 

Related Resources

Related Resources

Alt text (EN) This picture shows several doctors looking at a medical image within the program mint Lesion™

On-Site BZKF BORN Roll-Out Trainings Keep on Going

Our expert Steffen Rupp recently visited the Technical University of Munich to continue the on-site BZKF BORN Roll-Out Trainings. As mentioned…

This image shows a scan of pericardial effusion

Unveiling the Predictive Power of Pericardial Effusion in COVID-19 Outcomes

The COVID-19 pandemic wreaked havoc on healthcare systems worldwide, requiring a comprehensive understanding of disease progression for optimal…

Image shows two open hands holding a gray cancer ribbon in their palms

Advancing Childhood Cancer Research: The Role of Technology in Brain Tumor Diagnosis and Treatment

Brain cancers account for more than 15% of childhood cancers and are the second most common childhood cancer [1]. Mint Medical is Going Gray in May…